|
09 Oct 2017 |
News |
Zilretta - a New Drug FDA Approved for Osteoarthritis of the Knee |
|
|
27 Sep 2017 |
Social |
In Australia 2015 to 2030, OA numbers are expected to incr 41%; RA by 37%, with cost of care rising by 37% for both. https://t.co/BNc2P4CyU3 |
|
|
27 Sep 2017 |
News |
UAB Researchers Shed Light on Age-Related Osteoporosis |
|
|
21 Sep 2017 |
News |
Osteoporotic Fractures as Back Pain in Older Men |
|
|
19 Sep 2017 |
News |
Romosuzumab Followed by Alendronate is Best in Fracture Prevention |
|
|
18 Sep 2017 |
Social |
50 pt trial of steroid injx vs wrist splinting for carpal tunnel syndr shows injx w/ better dexterity, satisfaction https://t.co/0gaYCURTOR |
|
|
14 Sep 2017 |
Social |
After 3-5yrs bisphosphonates in postmenopausal OP women, BP Drug holiday assoc w/ 40% higher risk of new fractures https://t.co/N19RKPQGVx |
|
|
05 Sep 2017 |
Social |
RT @ProfDavidHunter: Suggestions that the knee injection technique (approach) can influence treatment efficacy https://t.co/2V7P4q50kr http… |
|
|
04 Sep 2017 |
Social |
RT @philipcrobinson: Really interesting article on observation that beta blockers reduce joint pain and opioid use in osteoarthritis #OA ht… |
|
|
04 Sep 2017 |
Social |
RT @jesdaile: The best long-term solution for arthritis is research on prevention and control https://t.co/YyBwvuuL2d |
|
|
21 Aug 2017 |
Social |
In UK, RA + OA Arthritis will cause 25.9 million lost working days costing £3.43 billion by 2030 https://t.co/IakiW4FVn6 |
|
|
17 Aug 2017 |
News |
Bad Knees Through the Ages |
|
|
17 Aug 2017 |
News |
Osteoporosis Care for RA Patients Found Suboptimal, Declining |
|
|
13 Aug 2017 |
Social |
Hip & Knee pain is linked to Increasing Temperature (betw -5 & 30C), Not Rainfall https://t.co/y6myodGZ1Z |
|
|
11 Aug 2017 |
News |
Kids with Crohn's have Profound MSK Deficits - but No Increase in Fractures |
|
|
10 Aug 2017 |
News |
Joint Pain Linked to Increasing Temperature, Not Rainfall |
|
|
02 Aug 2017 |
News |
Romosuzumab Outperforms Teriparatide in Post-Bisphosphonate Osteoporosis |
|
|
02 Aug 2017 |
Social |
Amgen submitted its Biologic Licence application to the FDA for Denosumab in Rx of Glucorticoid induced Osteoporosis https://t.co/MdKOssFggV |
|
|
28 Jul 2017 |
Social |
Intraarticular small-molecule Wnt inhibitor SM04690 phase II trial successful in knee OA https://t.co/1zZHpajOq0 https://t.co/YYGYxy8qZZ |
|
|
27 Jul 2017 |
News |
Denosumab Increases Trabecular Bone |
|
